Systemic Inflammation Index as a Novel Biomarker of No-Reflow Phenomenon in Patients With Acute Myocardial Infarction

Abstract

Get full access to this article

View all access options for this article.

References

Çelik

Karayiğit

Ozkan

Dolu

Kalçık

. Relationship between systemic inflammation index and no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Angiology. 2023;74:387-394.

Dai

Kong

Zhang

Luan

Wang

Hou

. Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon. BMC Cardiovasc Disord. 2022;22:362.

Esenboğa

Kurtul

Yamantürk

Tan

Tutar

. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2022;77:59-65.

Özkan

Gürdoğan

Öztürk

, et al. Systemic immune-inflammation index: A novel predictor of coronary thrombus burden in patients with non-ST acute coronary syndrome. Medicina (Kaunas). 2022;58:143.

Allencherril

Jneid

Atar

, et al. Pathophysiology, diagnosis, and management of the no-reflow phenomenon. Cardiovasc Drugs Ther. 2019;33:589-597.

Di Virgilio

New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets. Curr Pharm Des. 2004;10(14):1647-1652.

Della Corte

Tuttolomondo

Pecoraro

Di Raimondo

Vassallo

Pinto

. Inflammation, endothelial dysfunction and arterial stiffness as therapeutic targets in cardiovascular medicine. Curr Pharm Des. 2016;22:4658-4668.